SELLAS Life Sciences (SLS) Return on Sales Growth (1y) (2014 - 2022)

SELLAS Life Sciences (SLS) Return on Sales Growth (1y) (2014 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 SELLAS Life Sciences 3.23 Mn 3.23 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 -39.00
Sep 30, 2022 -43.00
Jun 30, 2022 -42.00
Mar 31, 2022 -16.00
Dec 31, 2021 -1.00
Sep 30, 2021 2.00
Jun 30, 2021 -1.00
Mar 31, 2021 0.00
Jun 30, 2015 9.00
Mar 31, 2015 6.00
Dec 31, 2014 1.00
Sep 30, 2014 2.00
Jun 30, 2014 -5.00
Mar 31, 2014 -3.00